Daxor Profit Margin

The latest profit margin for DXR is 924.1% as of June 2026. That compares with 27.51% in the prior-year period — up 3259.4% year over year. That is above the Healthcare sector average of 13.76%. Investors often review this figure alongside Daxor's historical trend and sector peers before judging valuation or financial health.

Over the past year, DXR's profit margin moved from 27.51% to 924.1% — a 3259.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Daxor's valuation or profitability profile.

Against Healthcare companies, DXR currently prints 924.1% for profit margin, while the sector average sits near 13.76%. That is roughly 6615.7% above the sector mean. Large gaps often invite a closer look at Daxor's growth, margins, and balance sheet.

Profit Margin shows how effectively Daxor converts resources into returns. At 924.1%, DXR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 27.51% in the prior-year period — up 3259.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DXR's profit margin (924.1%), review year-over-year change from 27.51%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.